This is a rare inherited condition. It's a type of metabolic disorder where a substance called sulfatide builds up inside cells, especially in the brain. This buildup can cause problems with brain function and development.
Every report comes from a Lived member, sent anonymously.
Have you had Stem Cell Transplant for Sulfatidosis?
Sulfatidosis is a rare inherited condition in which fatty substances called sulfatides build up inside cells because the body cannot break them down. The buildup mainly harms myelin, the protective coating around nerves, gradually damaging the brain, spinal cord and nerves to the limbs. People slowly lose movement, speech, thinking and other skills they once had. The main form is metachromatic leukodystrophy (MLD), grouped by age at onset: late-infantile MLD begins before about two and a half years, juvenile MLD between then and age 16, and adult MLD later. Earlier onset usually means faster progression. A rarer relative, multiple sulfatase deficiency, also affects the skin and skeleton.
MLD is genetic. Most cases come from changes in the gene for arylsulfatase A, the enzyme that breaks down sulfatides; a few involve a helper protein called saposin B. The condition is recessive, meaning a child is affected only after inheriting a changed copy from each parent. Carrier parents are usually healthy, and when both are carriers, each pregnancy has a 1 in 4 chance of an affected child. Nothing a parent did causes it.
Doctors suspect MLD when someone loses skills over time, such as a toddler who becomes clumsy, falls often or starts toe walking, or an older child whose schoolwork and behavior decline. A brain MRI (magnetic resonance imaging) scan shows characteristic damage to the brain's white matter, its myelin-rich parts. Blood tests measure arylsulfatase A activity, and genetic testing looks for changes in both copies of the gene. A urine test showing high sulfatide levels helps confirm the diagnosis, because some healthy people have low enzyme readings without disease. Once a family's gene changes are known, brothers and sisters can be tested, which matters because treatment works best before symptoms start.
There is no cure, and treatment depends heavily on timing. Atidarsagene autotemcel (Lenmeldy) is a one-time gene therapy for children with late-infantile or early-juvenile MLD who have no symptoms yet, or early-juvenile MLD with only early symptoms. Doctors collect the child's own blood-forming stem cells, add a working copy of the gene and return the cells after chemotherapy. In studies, treated children were much less likely to lose the ability to walk and sit than untreated children. The process is intensive, carries serious risks such as infection, and is offered only at specialist centers. For some people with juvenile or adult MLD and few or no symptoms, a donor stem cell transplant can slow nervous system damage. Once the disease is advanced, these options no longer help, and care focuses on comfort and function: seizure medicines, physical and occupational therapy, mobility equipment and feeding support, sometimes including a feeding tube.
The course depends on the form. Late-infantile MLD typically progresses over a few years and shortens life. Juvenile and adult forms move more slowly, sometimes over decades, with stretches of stability between periods of decline. Children treated early with gene therapy may keep many abilities, though long-term results are still being studied. A neurologist usually coordinates care with therapists and other specialists, using regular MRI scans and checks of movement, feeding, vision, hearing and breathing. Feverish illnesses can be followed by a setback. Families often need practical support and planning as care needs change.
Ask for an evaluation if a child loses skills such as walking or talking, or an older child or adult shows unexplained decline at school or work with changes in coordination or behavior. If a relative has MLD, ask soon about testing siblings, since treatment depends on catching it early. For someone already diagnosed, contact the care team promptly about a fever or infection followed by lost abilities, or new trouble swallowing.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Sulfatidosis is like, what's helped you, or ask the community a question.